Octavio Romero, predoctoral researcher at the gene and cancer group at IDIBELL leaded by Dr. Montserrat S\u00e1nchez-C\u00e9spedes, got the RTICC 2012 research award in oncology, organized by the Thematic Network of Cooperative Research on Cancer (Red Tem\u00e1tica de Investigaci\u00f3n Cooperativa en C\u00e1ncer, RTICC) by the paper entitled \u201cThe tumour suppressor and chromatin-remodelling factor BRG1 antagonizes Myc activity and promotes cell differentiation in human cancer\u201d.<\/p>\n
The award was given at the conclusion of the Third Scientific Meeting of Young Researchers RTICC 2012, which took place at the Hospital Vall d’Hebron in Barcelona on 19th and 20th November 2012, and it consisted of a diploma, a memorial object and a prize of 3,000 euros to finance training or candidate’s research awarded. The award included an oral presentation of the winning paper at the meeting by the researcher awarded on last 20th November.<\/p>\n
Reference of the paper<\/strong> Octavio Romero, predoctoral researcher at the gene and cancer group at IDIBELL leaded by Dr. Montserrat S\u00e1nchez-C\u00e9spedes, got the RTICC 2012 research award in oncology, organized by the Thematic Network of Cooperative Research on Cancer (Red Tem\u00e1tica de Investigaci\u00f3n Cooperativa en C\u00e1ncer, RTICC) by the paper entitled \u201cThe tumour suppressor and chromatin-remodelling factor BRG1 antagonizes […]<\/p>\n","protected":false},"author":6,"featured_media":20080,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"no-sidebar","site-content-layout":"page-builder","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"footnotes":""},"categories":[230],"tags":[],"publishpress_future_action":{"enabled":false,"date":"2024-05-10 08:46:50","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category"},"_links":{"self":[{"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/posts\/6526"}],"collection":[{"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/comments?post=6526"}],"version-history":[{"count":2,"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/posts\/6526\/revisions"}],"predecessor-version":[{"id":20081,"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/posts\/6526\/revisions\/20081"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/media\/20080"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/media?parent=6526"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/categories?post=6526"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/tags?post=6526"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\n<\/strong> Romero OA, Setien F, John S, Gimenez-Xavier P, G\u00f3mez-L\u00f3pez G, Pisano D, Condom E, Villanueva A, Hager GL, Sanchez-Cespedes. The tumour suppressor and chromatin-remodelling factor BRG1 antagonizes Myc activity and promotes cell differentiation in human cancer. M. EMBO Mol Med. 2012 Jul; 4(7): 603-16. doi: 10.1002\/emmm.201200236. Epub 2012 Apr 11. PMID: 22407764<\/p>\n","protected":false},"excerpt":{"rendered":"